Skip to main content
Erschienen in: Clinical Rheumatology 10/2017

04.07.2017 | Original Article

Serum levels of the bone turnover markers dickkopf-1, osteoprotegerin, and TNF-α in knee osteoarthritis patients

verfasst von: Sicong Min, Chao Wang, Wanli Lu, Zhihong Xu, Dongquan Shi, Dongyang Chen, Huajian Teng, Qing Jiang

Erschienen in: Clinical Rheumatology | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Knee osteoarthritis (KOA) is a common degenerative joint disease causing pain, stiffness, reduced motion, swelling, crepitus, and disability. Several inflammatory markers and cartilage degradation products can be used as biomarkers in OA. The key factors of bone metabolism in normal joint bone, dickkopf-1 (DKK1) and osteoprotegerin (OPG), interact with Wnt signaling pathway, balancing between bone absorption and bone reconstruction. TNF-α is a key inducer of DKK-1, which belongs to the family of proteins involved in joint remodeling. The present study compared the serum levels of DKK1, TNF-α, and OPG in patients with KOA and healthy controls to analyze the interrelationship and the severity of joint destruction. One hundred forty-eight patients with KOA and 101 healthy controls were enrolled in this study. Anteroposterior knee radiographs determined the severity of the disease in the affected knee. The radiographic grading of KOA was performed by the Kellgren–Lawrence criteria. Serum levels of DKK-1, TNF-α, and OPG were estimated using the multiplex particle-based flow cytometry. Higher serum levels of OPG and TNF-α were observed in KOA than the controls; KOA patients showed a lower serum level of DKK-1, whereas the serum levels of DKK1 correlated with the progression of KOA. The serum levels of TNF-α, OPG, and DKK-1 correlated with incident KOA. In the ROC curve analysis, DKK1 levels showed 78.6% sensitivity and 40% specificity, TNF-α levels showed 74.1% sensitivity and 76.0% specificity, and OPG showed 88.1% sensitivity and 81% specificity in predicting severe KOA. In the univariate and multivariate analyses, TNF-α and OPG emerged as independent predictors of severe KOA. This study, for the first time, combined TNF-α, DKK1, and OPG as valuable biological markers in predicting the severity of KOA radiographically in the clinic. This study also supported the inflammation-induced DKK1 and OPG in OA pathogenesis.
Literatur
1.
Zurück zum Zitat Güler Uysal F, Başaran S (2009) Knee osteoarthritis. Turk J Phys Med Rehab 55(Suppl 1):1–7 Güler Uysal F, Başaran S (2009) Knee osteoarthritis. Turk J Phys Med Rehab 55(Suppl 1):1–7
2.
Zurück zum Zitat Sellam J, Berenbaum F (2013) Is osteoarthritis a metabolic disease? Joint Bone Spine 80:568–573CrossRefPubMed Sellam J, Berenbaum F (2013) Is osteoarthritis a metabolic disease? Joint Bone Spine 80:568–573CrossRefPubMed
3.
Zurück zum Zitat Wang X, Hunter D, Xu J et al (2015) Metabolic triggered inflammation in osteoarthritis. Osteoarthr Cartil 23:22–30CrossRefPubMed Wang X, Hunter D, Xu J et al (2015) Metabolic triggered inflammation in osteoarthritis. Osteoarthr Cartil 23:22–30CrossRefPubMed
4.
Zurück zum Zitat Henrotin Y (2012) Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives[J]. Osteoarthr Cartil 20(3):215–217CrossRefPubMed Henrotin Y (2012) Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives[J]. Osteoarthr Cartil 20(3):215–217CrossRefPubMed
5.
Zurück zum Zitat Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349(26):2483–2494CrossRefPubMed Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy JD Jr (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349(26):2483–2494CrossRefPubMed
6.
Zurück zum Zitat Morvan F et al (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21:934–945CrossRefPubMed Morvan F et al (2006) Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21:934–945CrossRefPubMed
7.
Zurück zum Zitat Tian E et al (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349:2483–2494CrossRefPubMed Tian E et al (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349:2483–2494CrossRefPubMed
8.
Zurück zum Zitat Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13(2):15663CrossRef Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D et al (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13(2):15663CrossRef
9.
Zurück zum Zitat Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H et al (2012) High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 71(4):572–574CrossRefPubMed Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H et al (2012) High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 71(4):572–574CrossRefPubMed
10.
Zurück zum Zitat Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M et al (2010) Evidence that dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62:150–158CrossRefPubMed Daoussis D, Liossis SN, Solomou EE, Tsanaktsi A, Bounia K, Karampetsou M et al (2010) Evidence that dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 62:150–158CrossRefPubMed
11.
Zurück zum Zitat Keffer J et al (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031PubMedPubMedCentral Keffer J et al (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031PubMedPubMedCentral
12.
Zurück zum Zitat Simonet WS, Lacey DL, Dunstan CR, Kelley MJ, Chang MS, Luthy R et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319CrossRefPubMed Simonet WS, Lacey DL, Dunstan CR, Kelley MJ, Chang MS, Luthy R et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309–319CrossRefPubMed
13.
Zurück zum Zitat Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490–495CrossRefPubMed Hofbauer LC, Schoppet M (2004) Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 292:490–495CrossRefPubMed
14.
Zurück zum Zitat Pilichou A, Papassotiriou I, Michalakakou K, Fessatou S, Fandridis E, Papachristou G, Terpos E (2008) High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem 41(9):746–749CrossRefPubMed Pilichou A, Papassotiriou I, Michalakakou K, Fessatou S, Fandridis E, Papachristou G, Terpos E (2008) High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem 41(9):746–749CrossRefPubMed
15.
Zurück zum Zitat Corrado A et al (2013) RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. J Rheumatol 40(5):684–694CrossRefPubMed Corrado A et al (2013) RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. J Rheumatol 40(5):684–694CrossRefPubMed
16.
Zurück zum Zitat Shimizu S, Asou Y, Itoh S et al (2007) Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis. Arthritis Rheum 56:3358–3365CrossRefPubMed Shimizu S, Asou Y, Itoh S et al (2007) Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis. Arthritis Rheum 56:3358–3365CrossRefPubMed
17.
Zurück zum Zitat Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H et al (2005) Canonical Wnt signalling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751–764CrossRefPubMed Glass DA, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H et al (2005) Canonical Wnt signalling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751–764CrossRefPubMed
18.
Zurück zum Zitat Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29(8):1039–1049CrossRefPubMed Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29(8):1039–1049CrossRefPubMed
20.
Zurück zum Zitat Lane NE, Nevitt MC, Lui LY, de Leon P, Corr M (2007) Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 56(10):3319–3325CrossRefPubMed Lane NE, Nevitt MC, Lui LY, de Leon P, Corr M (2007) Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 56(10):3319–3325CrossRefPubMed
21.
Zurück zum Zitat Honsawek S, Tanavalee A, Yuktanandana P et al (2010) Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients[J]. BMC Musculoskelet Disord 11(1):257CrossRefPubMedPubMedCentral Honsawek S, Tanavalee A, Yuktanandana P et al (2010) Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients[J]. BMC Musculoskelet Disord 11(1):257CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Honsawek S, Chayanupatkul M, Tanavalee A, Sakdinakiattikoon M, Deepaisarnsakul B, Yuktanandana P, Ngarmukos S (2009) Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study. Int Orthop 33:1171–1175CrossRefPubMedPubMedCentral Honsawek S, Chayanupatkul M, Tanavalee A, Sakdinakiattikoon M, Deepaisarnsakul B, Yuktanandana P, Ngarmukos S (2009) Relationship of plasma and synovial fluid BMP-7 with disease severity in knee osteoarthritis patients: a pilot study. Int Orthop 33:1171–1175CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M, Yuktanandana P (2009) Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 42:808–812CrossRefPubMed Honsawek S, Tanavalee A, Sakdinakiattikoon M, Chayanupatkul M, Yuktanandana P (2009) Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis. Clin Biochem 42:808–812CrossRefPubMed
24.
Zurück zum Zitat Scanzello CR, Umoh E, Pessler F, Diaz-Torne C, Miles T, Dicarlo E (2009) Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthr Cartil 17:1040–1048CrossRefPubMed Scanzello CR, Umoh E, Pessler F, Diaz-Torne C, Miles T, Dicarlo E (2009) Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthr Cartil 17:1040–1048CrossRefPubMed
25.
Zurück zum Zitat Nelson AE, Fang F, Shi XA, Kraus VB, Stabler T, Renner JB (2009) Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project. Osteoarthr Cartil 17:772–776CrossRefPubMed Nelson AE, Fang F, Shi XA, Kraus VB, Stabler T, Renner JB (2009) Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project. Osteoarthr Cartil 17:772–776CrossRefPubMed
26.
Zurück zum Zitat Weng LH, Wang CJ, Ko JY, Sun YC, Su YS, Wang FS (2009) Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint. Osteoarthr Cartil 17:933–943CrossRefPubMed Weng LH, Wang CJ, Ko JY, Sun YC, Su YS, Wang FS (2009) Inflammation induction of Dickkopf-1 mediates chondrocyte apoptosis in osteoarthritic joint. Osteoarthr Cartil 17:933–943CrossRefPubMed
27.
Zurück zum Zitat Weng LH, Wang CJ, Ko JY, Sun YC, Wang FS (2010) Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum 62:1393–1402CrossRefPubMed Weng LH, Wang CJ, Ko JY, Sun YC, Wang FS (2010) Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum 62:1393–1402CrossRefPubMed
28.
Zurück zum Zitat Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, Martel-Pelletier J (2002) Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E 2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthr Cartil 10(6):491–500CrossRefPubMed Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G, Duval N, Martel-Pelletier J (2002) Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E 2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthr Cartil 10(6):491–500CrossRefPubMed
29.
Zurück zum Zitat Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S et al (2005) Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 146(12):5204–5214CrossRefPubMed Take I, Kobayashi Y, Yamamoto Y, Tsuboi H, Ochi T, Uematsu S et al (2005) Prostaglandin E2 strongly inhibits human osteoclast formation. Endocrinology 146(12):5204–5214CrossRefPubMed
30.
Zurück zum Zitat Lecourt S, Mouly E, Freida D, Cras A, Ceccaldi R, Heraoui D et al (2013) A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients. PLoS One 8(7):e69293CrossRefPubMedPubMedCentral Lecourt S, Mouly E, Freida D, Cras A, Ceccaldi R, Heraoui D et al (2013) A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients. PLoS One 8(7):e69293CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Tat S K, Amiable N, Pelletier J P, et al. (2009) Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis[J]. Rheumatology: kep300 Tat S K, Amiable N, Pelletier J P, et al. (2009) Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis[J]. Rheumatology: kep300
32.
Zurück zum Zitat Tat SK, Pelletier JP, Velasco CR et al (2009) New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?[J]. The Keio journal of medicine 58(1):29–40CrossRefPubMed Tat SK, Pelletier JP, Velasco CR et al (2009) New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?[J]. The Keio journal of medicine 58(1):29–40CrossRefPubMed
33.
Zurück zum Zitat Hofbauer LC, Schoppet M (2001) Serum measurement of osteoprotegerin—clinical relevance and potential applications. Eur J Endocrinol 145:681–683CrossRefPubMed Hofbauer LC, Schoppet M (2001) Serum measurement of osteoprotegerin—clinical relevance and potential applications. Eur J Endocrinol 145:681–683CrossRefPubMed
34.
Zurück zum Zitat Khosla S, Arrighi HM, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Dunstan C, Riggs BL (2002) Correlates of osteoprotegerin levels in women and men. Osteoporos Int 13:394–399CrossRefPubMed Khosla S, Arrighi HM, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Dunstan C, Riggs BL (2002) Correlates of osteoprotegerin levels in women and men. Osteoporos Int 13:394–399CrossRefPubMed
35.
Zurück zum Zitat Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N, Gouin F, Redini F, Heymann D (2003) Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 163:2021–2031CrossRefPubMedPubMedCentral Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N, Gouin F, Redini F, Heymann D (2003) Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis. Am J Pathol 163:2021–2031CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Rogers A, Eastell R (2005) Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 90:6323–6331CrossRefPubMed Rogers A, Eastell R (2005) Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 90:6323–6331CrossRefPubMed
37.
Zurück zum Zitat Chan BY, Fuller ES, Russell AK, Smith SM, Smith MM, Jackson MT, Cake MA, Read RA, Bateman JF, Sambrook PN et al (2011) Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 19(7):874–885CrossRef Chan BY, Fuller ES, Russell AK, Smith SM, Smith MM, Jackson MT, Cake MA, Read RA, Bateman JF, Sambrook PN et al (2011) Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 19(7):874–885CrossRef
38.
Zurück zum Zitat Wang SY, Liu YY, Ye H et al (2011) Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. J Rheumatol 38(5):821–827CrossRefPubMed Wang SY, Liu YY, Ye H et al (2011) Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis. J Rheumatol 38(5):821–827CrossRefPubMed
39.
Zurück zum Zitat Glass DA, Bialek P, Ahn JD et al (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8(5):751–764CrossRefPubMed Glass DA, Bialek P, Ahn JD et al (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8(5):751–764CrossRefPubMed
41.
Zurück zum Zitat Goldring SR, Goldring MB (2007) Eating bone or adding it: the wnt pathway decides. Nat Med 13:133–134CrossRefPubMed Goldring SR, Goldring MB (2007) Eating bone or adding it: the wnt pathway decides. Nat Med 13:133–134CrossRefPubMed
43.
Zurück zum Zitat Lotz M, Martel-Pelletier J, Christiansen C et al (2013) Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 72:1756–1763CrossRefPubMedPubMedCentral Lotz M, Martel-Pelletier J, Christiansen C et al (2013) Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 72:1756–1763CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Saberi Hosnijeh F, Siebuhr AS, Uitterlinden AG et al (2015) Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort. Arthritis Research & Therapy 18(1):81CrossRef Saberi Hosnijeh F, Siebuhr AS, Uitterlinden AG et al (2015) Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort. Arthritis Research & Therapy 18(1):81CrossRef
Metadaten
Titel
Serum levels of the bone turnover markers dickkopf-1, osteoprotegerin, and TNF-α in knee osteoarthritis patients
verfasst von
Sicong Min
Chao Wang
Wanli Lu
Zhihong Xu
Dongquan Shi
Dongyang Chen
Huajian Teng
Qing Jiang
Publikationsdatum
04.07.2017
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 10/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3690-x

Weitere Artikel der Ausgabe 10/2017

Clinical Rheumatology 10/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.